Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-17 · accession 0001104659-23-035049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-21 | 2023-03-17 | INSP | McCormick Shawn | Dir | M - OptEx | $0.94 | +4,000 | 11.5K | +53% | +$3,760 |
| D | 2023-03-21 | 2023-03-17 | INSP | McCormick Shawn | Dir | M - OptEx | $0.00 | -4,000 | 3,519 | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | M | A | 4,000 | $0.94 | 11,518 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-17 | M | D | 4,000 | $0.00 | 3,519 | D | $0.94 · — to 2027-01-01 | 4,000 Common Stock | (F2) The amount of options originally reported in the Reporting Person's Form 3 dated May 2, 2018 understated the number of shares of common stock underlying the option by one share. (F1) The option is fully vested and exercisable. |